| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-269962 hydrochloride |
|---|
| Description | MW: 607.07. Purity ≥98% by HPLC. GSK-269962 is a potent and selective Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively). It displays >30-fold selectivity for ROCK against a panel of serine/threonine kinases. Induces vasorelaxation in preconstricted rat aorta (IC50 = 35 nM) and lowers blood pressure in a rat model of hypertension. |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | GSK26996B, GSK-269962A, N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide hydrochloride, GSK269962 |
|---|
| Gene, Accession, CAS # | CAS: 2095432-71-4 |
|---|
| Catalog # | B2425-25 |
|---|
| Price | |
|---|
| Order / More Info | GSK-269962 hydrochloride from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|